These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1406500)

  • 1. Elevated lead burden in Chinese patients without occupational lead exposure.
    Lin JL; Lim PS
    Miner Electrolyte Metab; 1992; 18(1):1-5. PubMed ID: 1406500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult lead intoxication as a cause of hypertension and renal failure.
    Sánchez-Fructuoso AI; Torralbo A; Arroyo M; Luque M; Ruilope LM; Santos JL; Cruceyra A; Barrientos A
    Nephrol Dial Transplant; 1996 Sep; 11(9):1775-80. PubMed ID: 8918621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occult lead intoxication in patients with gout and kidney disease.
    Wright LF; Saylor RP; Cecere FA
    J Rheumatol; 1984 Aug; 11(4):517-20. PubMed ID: 6434739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does lead play a role in the development of renal insufficiency in some patients with essential hypertension?
    Lin JL; Lim PS
    J Hum Hypertens; 1994 Jul; 8(7):495-500. PubMed ID: 7932512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body lead stores and urate excretion in men with chronic renal disease.
    Lin JL; Huang PT
    J Rheumatol; 1994 Apr; 21(4):705-9. PubMed ID: 8035397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
    Lin JL; Lin-Tan DT; Hsu KH; Yu CC
    N Engl J Med; 2003 Jan; 348(4):277-86. PubMed ID: 12540640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary lead excretion in uremic patients.
    Behringer D; Craswell P; Mohl C; Stoeppler M; Ritz E
    Nephron; 1986; 42(4):323-9. PubMed ID: 3083277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic lead poisoning: Lead gout with giant tophi on the skin, nephrophathy and porphyrinopathy].
    Orfanos CE; Künzig M
    Hautarzt; 1975 Nov; 26(11):581-4. PubMed ID: 812845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout.
    Lin JL; Yu CC; Lin-Tan DT; Ho HH
    Kidney Int; 2001 Jul; 60(1):266-71. PubMed ID: 11422760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated body lead burden from drinking water in end-stage chronic renal failure.
    Kessler M; Durand PY; Hestin D; Cao Huu T; Renoult E; Prenat E; Chanliau J; Kaminski P; Duc M
    Nephrol Dial Transplant; 1995; 10(9):1648-53. PubMed ID: 8559484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ["Terzo fuoco", lead poisoning and chronic renal failure].
    Bonucchi D; Mondaini G; Ravera F; Minisci E; Albertazzi V; Arletti S; Mori G; Ballestri M; Piattoni J; Cappelli G
    G Ital Nefrol; 2007; 24 Suppl 38():76-9. PubMed ID: 17922453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-level environmental exposure to lead and progressive chronic kidney diseases.
    Lin JL; Lin-Tan DT; Li YJ; Chen KH; Huang YL
    Am J Med; 2006 Aug; 119(8):707.e1-9. PubMed ID: 16887418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases.
    Lin-Tan DT; Lin JL; Yen TH; Chen KH; Huang YL
    Nephrol Dial Transplant; 2007 Oct; 22(10):2924-31. PubMed ID: 17556414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead and the kidney: nephropathy, hypertension, and gout.
    Perazella MA
    Conn Med; 1996 Sep; 60(9):521-6. PubMed ID: 8908777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of lead excretion in patients with gout and chronic renal failure--a comparative German and Australian study.
    Craswell PW; Price J; Boyle PD; Behringer D; Stoeppler M; Ritz E
    Sci Total Environ; 1987 Oct; 66():17-28. PubMed ID: 3120309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lead accumulation as a possible cause of renal failure in gouty patients.
    Colleoni N; D'Amico G
    Nephron; 1986; 44(1):32-5. PubMed ID: 3092121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case of lead nephropathy due to chronic occupational lead exposure].
    Ogata A; Sueta S; Tagawa M
    Nihon Jinzo Gakkai Shi; 2011; 53(2):207-11. PubMed ID: 21516708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output.
    Perez-Ruiz F; Calabozo M; Erauskin GG; Ruibal A; Herrero-Beites AM
    Arthritis Rheum; 2002 Dec; 47(6):610-3. PubMed ID: 12522834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.